EHR Selection: The Executive Evaluation Framework
Choosing an Electronic Health Record (EHR) platform is one of the most resource-intensive and operationally consequential technology decisions a healthcare enterprise will ever make. The selected system touches every clinical workflow, shapes provider efficiency, and heavily influences long-term financial agility. In our experience advising on these programs, rushing selection timelines to meet arbitrary administrative deadlines is a leading cause of troubled deployments, extended productivity drops, and severe budget overruns — the pressure saved in procurement is repaid with interest in implementation.
To keep the evaluation objective across competing vendor proposals, executive leadership should deploy a structured scorecard framework: every criterion explicitly scored and weighted according to the organization's strategic priorities before reviewing any vendor submission — never after. In our experience this single discipline is the most effective protection against retrospective bias and vendor-driven feature drift.
Five Strategic Evaluation Dimensions
1. Clinical Usability & Burnout Risk
System efficiency and interface design directly affect provider wellbeing and retention. The evidence is substantial: KLAS Arch Collaborative data shows that roughly a third of physicians (32%) report some level of burnout — and among those, 62% cite the EHR as a contributor [1]. Peer-reviewed analysis of the same Collaborative's data across 25,018 physicians found that those spending five or fewer hours per week on after-hours charting were about twice as likely to report lower burnout than those charting six or more [2]. Evaluation teams should therefore measure what drives those hours — active charting speed, cognitive load, ordering click-counts — rather than checking generic vendor feature lists.
2. Ecosystem Interoperability & Core Stack Integration
Clinical data liquidity across the network is mandatory to prevent information silos. The platform must provide open, standards-based APIs (HL7 FHIR for exchange, HL7 v2 for clinical messaging) and integrate with laboratory (LIS) and radiology (RIS) systems without a portfolio of expensive custom middleware. In our experience, interoperability claims should be tested against your actual integration inventory during evaluation — not discovered against it after contract signature.
3. Regulatory Compliance & Active Certification
The platform must hold active federal or regional health IT certification validating privacy safeguards, audit trails, and public health reporting. In the United States, the ONC Health IT Certification Program defines the criteria [3] — including Electronic Health Information (EHI) export (§ 170.315(b)(10)), required for certified health IT that stores EHI, and a multi-factor authentication attestation criterion (§ 170.315(d)(13)). Verified certification status materially reduces regulatory and litigation exposure; no compliance posture eliminates it. Note that the EHI export criterion is also a practical exit-strategy test: it exists precisely so your data can leave the system.
4. Real Total Cost of Ownership (TCO)
Financial models must extend far beyond licensing or subscription fees. In our experience a realistic capital strategy models a 5-to-10-year horizon covering clinical data migration, architecture upgrades, post-live clinical optimization, and rolling training pipelines for rotating staff. The line items vendors quote are rarely the line items that dominate the decade.
5. Scale Alignment & Vendor Track Record
Implementation research indexed by AHRQ identifies scale as an important differentiator: systems and vendors proven in one operational footprint do not automatically transfer to another, and products designed for large environments are a documented barrier in smaller ones [4]. In our experience, a vendor's demonstrated history at comparable scale, transaction volume, and specialty mix is among the strongest predictors of long-term adoption success — reference-check against organizations that look like yours, not the vendor's flagship.
The Selection Governance Structure
In our experience, governance matters as much as the technology being governed — structured, multi-stakeholder selection processes are a long-established best practice in healthcare IT procurement [5]. From day one, the steering committee should integrate four co-equal, multi-disciplinary pillars:
- Clinical Champions: Active staff physicians and senior nursing leaders auditing interface friction, patient safety layouts, and daily adoptability.
- IT & Systems Leadership: Enterprise architects and security officers evaluating database structures, API throughput, interface performance, and cybersecurity risk.
- Compliance Officers: Legal counsel and data protection specialists reviewing data ownership terms, liability boundaries, regional privacy mandates, and audit log permanency.
- Financial Stakeholders: Analysts and procurement officers auditing contract scaling penalties, hidden support structures, and long-term TCO bounds.
Executive Takeaway
In our experience, an EHR transition is a total organizational transformation, not an IT software deployment. Managing a long-term cultural shift and complex workflow adjustment requires executive ownership of the operational objective before staff are ever trained on software functionality. Deep, structured pre-selection scoping is your strongest protection against implementation failure.
The Sixth Dimension: Data Ownership Beyond the EHR
There is a dimension most scorecards omit, and it outlasts every other line item: what happens to your clinical data when this EHR is no longer your EHR. Every platform on your shortlist will eventually be replaced, and the organizations that survive that transition cheaply are the ones whose authoritative clinical record was never locked inside the application in the first place. That means making data portability and open persistence standards — not just exchange APIs — explicit, weighted scorecard criteria: demonstrable export of the complete record, vendor-neutral data models, and contract terms that put data ownership beyond dispute.
This is where CaboLabs works. We provide vendor-neutral advisory for healthcare technology selection and interoperability strategy — evaluating candidate platforms' real standards conformance across HL7 FHIR, HL7 v2, and openEHR, designing the integration architecture around the chosen EHR, and structuring the data portability requirements that protect your record for decades. For organizations ready to go further, our openEHR-native clinical data repository, Atomik, anchors the strategy architecturally: a vendor-neutral, standards-based home for the longitudinal clinical record that persists across every application decision — including your next EHR. If an EHR selection is on your board agenda, talk to us at cabolabs.com before the scorecard is finalized; the cheapest time to protect your data is before you buy the system that will hold it.